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We report a case of Guillain-Barre syndrome (GBS) associated with Rocky Mountain spotted fever (RMSF). The patient initially presented with fever, rash, and an altered mental status, and he responded to therapy with intravenous doxycycline; serological data confirmed RMSF. Concurrent physical findings and results of cerebrospinal fluid analysis and nerve conduction studies were compatible with GBS. Although neurological complications of RMSF are common, no known associations between RMSF and GBS were found in the literature. An association between possible infection with Rickettsia conorii and GBS was reported in a French study in 1968. To our knowledge, this is the first reported association between RMSF and GBS.
Rocky Mountain spotted fever (RMSF) is the most frequently reported rickettsial disease in the United States [1, 2] . In addition, neurological manifestations have been described in up to two-thirds of patients with RMSF [3] . Guillain-Barre syndrome (GBS) is the most frequent cause of acute paralysis [4] , but GBS has not been previously reported as a complication of RMSF. GBS has been associated with several infectious agents, but Rickettsia rickettsii has not been previously reported in association with this syndrome [5] . To our knowledge, we report the first case of GBS associated with RMSF.
Case Report
A 48-year-old man from rural Maryland who had a history ofheadache, photophobia, and anorexia during the second week of July 1992 and fever, chills, nausea, and vomiting followed by the appearance of a truncal rash 2 days later was admitted to a community hospital after his symptoms worsened and his family noted that he was confused. Neurological examination at admission was notable for orientation to person and place only, normal sensory and motor function, and symmetrical reflexes. The serum sodium level was 125 mg/dL. His course was complicated by persistent fever (temperature to 38.6°C), a progressive rash, and a worsening mental status while he was receiving therapy with ceftriaxone, erythromycin, vancomycin, metronidazole, and acyclovir. On the fourth hospital day, '" 11 days after the onset of fever, doxycycline was added to the therapeutic regimen for rickettsial coverage. On the fifth hospital day, he was intubated because of pulmonary edema and transferred to our institution because of fever, rash, thrombocytopenia, and respiratory failure.
At our institution, a physical examination revealed an intubated man with a temperature of 38.2°C. His blood pressure was stable, but his pulse rate varied between 50 and 90 beats. A generalized, mottled, petechial rash extended from his trunk to his palms and soles. A thorough physical examination did not reveal an attached tick. Horizontal nystagmus and motor weakness were noted during a neurological examination. Laboratory evaluation showed the following: hematocrit, 30%; WBC count, 9,000/mm 3 , with a shift to the left; and platelet count, 52,000/mm 3 • There was no evidence of microangiopathic hemolytic anemia or disseminated intravascular coagulation. Antimicrobial therapy was changed to doxycycline alone, and he received aggressive diuretic treatment. Within 3 days, a total of 4 days after the therapeutic addition of doxycycline, he was extubated and transferred to the medical department. His fever (temperature to 38.2°C) continued for 17 days after doxycycline was added to his treatment. His mental status improved significantly; however, his neurological weakness progressed on the sixth day of doxycycline therapy. There were absent reflexes, diminished motor function in his arms and legs, and decreased sensation in his legs. A lumbar image did not reveal any evidence of cord compression. CSF analysis showed an elevated total protein level of 140 mg/dL without a cellular response. Findings ofnerve conduction studies (electromyography) were compatible with polyradiculomyelopathy or GBS. Therapy with intravenous immune globulin (IVIG) was started, and he slowly regained strength. Indirect immunofluorescent antibody studies ofpaired serum samples showed a rise in titers of antibody to R. rickettsii from 1: 128 to 1:512. A stool culture failed to reveal a pathogen, and serology for HIV antibody was nonreactive.
Discussion
Our patient had documented RMSF and subsequent GBS. A review of the literature on an association between GBS and rickettsial disease revealed a case report of GBS following a possible infection due to Rickettsia conorii [6] . There have NOTE. NR = not reported.
• Reported symptoms compatible with Guillain-Barre syndrome.
1091 been frequent reports of neurological complications associated with RMSF [3, [7] [8] [9] [10] [11] [12] , but GBS has not been discussed as a complication. In addition, the delay in therapy for our patient may have played a role in the development of his neurological sequela [13, 14] . The neurological complications of RMSF, including neurological sequelae that may resemble GBS, are summarized in table 1. The tick largely responsible for the transmission of RMSF in the eastern two-thirds of the United States is Dermacentor variabilis. This tick has also been implicated in tick paralysis [2] . A neurotoxin from the saliva of an embedded tick may lead to paralysis, usually beginning with symmetrical leg weakness. Examinations of blood and eSF are unremarkable, and symptoms generally abate quickly once the tick is removed. A diagnosis of GBS was considered in one case report before an embedded tick was discovered [15] . An exhaustive physical examination failed to reveal an embedded tick on our patient. In addition, features in our patient that support a diagnosis of GBS included symmetrical upper and lower extremity weakness, areflexia, increasing symptoms over days, mild sensory abnormalities, cranial nerve abnormalities, an elevated level of total protein in the eSF, and typical results of electrodiagnostic studies.
Infections with HIV, Epstein-Barr virus, and Campylobacter jejuni have been reported in association with GBS [16, 17] . Our patient had none of these antecedent illnesses. Although IVIG therapy may have had an impact on the titers of antibody to R. rickettsii in convalescent-phase sera, the initial titer of I: 128 was measured before the initiation of IVIG therapy, and we remain confident in our diagnosis of RMSF.
In summary, to our knowledge, this is the :first reported case ofGBS as a complicating feature ofRMSF. Neurological complications in patients with RMSF are common and should be anticipated. Frequent neurological examinations are indicated, and any patient with unexplained motor weakness should undergo an exhaustive search for an embedded tick. Therapy with doxycycline or chloramphenicol should be initiated promptly for suspected RMSF to prevent further complicating features, including neurological complications.
